BR9804395A - Long-acting, injectable pharmaceutical composition based on a tetracycline. - Google Patents
Long-acting, injectable pharmaceutical composition based on a tetracycline.Info
- Publication number
- BR9804395A BR9804395A BR9804395-1A BR9804395A BR9804395A BR 9804395 A BR9804395 A BR 9804395A BR 9804395 A BR9804395 A BR 9804395A BR 9804395 A BR9804395 A BR 9804395A
- Authority
- BR
- Brazil
- Prior art keywords
- long
- acting
- tetracycline
- pharmaceutical composition
- pharmaceutically acceptable
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçãO FARMACêUTICA INJETáVEL, DE LONGA AçãO, à BASE DE UMA TETRACICLINA"<D>. A presente invenção refere-se uma composição farmacêutica injetável, de longa ação, à base de um antimicrobiano do grupo das tetraciclinas, compreendendo, acondicionada em um único frasco, uma associação de um antimicrobiano do grupo das tetraciclinas com um antiinflamatório não-hormonal, em um excipiente de longa ação adequado, pronta para o uso, a dita composição sendo caracterizada pelo fato de que contém, como excipiente de longa ação, um excipiente de longa ação à base de óxido de magnésio ou cloreto de magnésio, polietilenoglicol 400 ou polietilenoglicol 200, monoetanolamina ou outras bases farmaceuticamente aceitáveis, formaldeído sulfoxilato de sódio ou outros agentes antioxidantes farmaceuticamente aceitáveis ou associações antioxidantes farmaceuticamente aceitáveis, tais como por exemplo formaldeído sulfoxilato de sódio com EDTA, e água desmineralizada ou osmotizada. A composição é utilizável para controle de germes Gram-positivos e Gram-negativos, algumas espécies de micoplasmas, protozoários e rickettsias, em bovinas, suínos, ovinos e caprinos, e é aplicável por via subcutânea (SC), intramuscular (IM) ou endovenosa (EV).Invention Patent: <B> "LONG-TERM INJECTION PHARMACEUTICAL COMPOSITION, BASED ON A TETRACYCLINE" <D>. The present invention relates to a long-acting injectable pharmaceutical composition based on an antimicrobial from the tetracycline group, comprising, packaged in a single bottle, an association of an antimicrobial from the tetracycline group with a non-hormonal anti-inflammatory, in a suitable long-acting excipient, ready for use, said composition being characterized by the fact that it contains, as a long-acting excipient, a long-acting excipient based on magnesium oxide or magnesium chloride, polyethylene glycol 400 or polyethylene glycol 200 , monoethanolamine or other pharmaceutically acceptable bases, sodium formaldehyde sulfoxylate or other pharmaceutically acceptable antioxidant agents or pharmaceutically acceptable antioxidant combinations, such as for example sodium formaldehyde sulfoxylate with EDTA, and demineralized or osmotized water. The composition is usable to control Gram-positive and Gram-negative germs, some species of mycoplasmas, protozoa and rickettsiae, in cattle, pigs, sheep and goats, and is applicable subcutaneously (SC), intramuscularly (IM) or intravenously (EV).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9804395-1A BR9804395A (en) | 1998-11-04 | 1998-11-04 | Long-acting, injectable pharmaceutical composition based on a tetracycline. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9804395-1A BR9804395A (en) | 1998-11-04 | 1998-11-04 | Long-acting, injectable pharmaceutical composition based on a tetracycline. |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9804395A true BR9804395A (en) | 2000-06-06 |
Family
ID=4070828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9804395-1A BR9804395A (en) | 1998-11-04 | 1998-11-04 | Long-acting, injectable pharmaceutical composition based on a tetracycline. |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR9804395A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9084802B2 (en) | 2010-05-12 | 2015-07-21 | Rempex Pharmaceuticals, Inc. | Tetracycline compositions |
-
1998
- 1998-11-04 BR BR9804395-1A patent/BR9804395A/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9084802B2 (en) | 2010-05-12 | 2015-07-21 | Rempex Pharmaceuticals, Inc. | Tetracycline compositions |
US9278105B2 (en) | 2010-05-12 | 2016-03-08 | Rempex Pharmaceuticals, Inc. | Tetracycline compositions |
US9744179B2 (en) | 2010-05-12 | 2017-08-29 | Rempex Pharmaceuticals, Inc. | Tetracycline compositions |
US11944634B2 (en) | 2010-05-12 | 2024-04-02 | Melinta Subsidiary Corp. | Tetracycline compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ504986A (en) | Erythromycin and azalide derivatives and pharmaceutical compositions thereof, useful as antibacterial agents and antoprotozoa agents | |
ES2178000T3 (en) | COMPOSITIONS AND METHODS TO TREAT INFECTIONS USING INDOLICIDINE ANALOGS. | |
BRPI0017013B8 (en) | azalide antibiotic composition and method for obtaining it | |
ES2157027T3 (en) | OXAZOLIDINONES REPLACED AND ITS USE AS ANTIBACTERIAL PHARMACOS. | |
ECSP034438A (en) | NEW PEPTIDES AS INHIBITORS OF NS-3-SERINA PROTEASA OF THE HEPATITIS C VIRUS | |
ES2150050T3 (en) | POLYACARIDS INTEGRATED WITH ANTIOXIDANTS AND ITS USE. | |
AR008444A1 (en) | EMPLOYMENT OF LEPTINE ANTAGONISTS FOR THE TREATMENT OF INSULIN RESISTANCE IN TYPE II DIABETES | |
AR041913A1 (en) | CONTROLLED RELEASE DEPOSIT FORMULATIONS | |
DE69923471D1 (en) | INJECTABLE PROPOFOL FORMULATIONS | |
BRPI0410884A (en) | feed composition for use in a pet, and method for weight control in a pet | |
PA8489501A1 (en) | CETOLID ANTIBIOTICS | |
ES2055406T3 (en) | COMPOSITION FOR THE TREATMENT OF INFLAMMATION. | |
AR043603A1 (en) | INJECTABLE COMPOSITIONS FOR INTRAMUSCULAR USE CONTAINING ESTERES OF TESTOSTERONE AND A VEHICLE THAT INCLUDES RICHINE OIL AND A WATER | |
BR0207978A (en) | N-but-3enyl norbuprenorphine and methods of use | |
PA8485601A1 (en) | AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS. | |
CO5011078A1 (en) | ORAL COMPOSITION THAT INCLUDES A CASEINE GLICOMACROPEPTIDE THAT HAS ANTIPLACY AND ANTICARIES ACTIVITY AND METHOD OF PREPARING IT | |
BR0009524A (en) | Use of a compound, and, pharmaceutical or veterinary composition | |
BR0315513A (en) | Injectable pharmaceutical composition, process for preparing pharmaceutical composition, and use of cefquinome in a vehicle with prolonged release | |
BR9408305A (en) | Compound pharmaceutical composition processes for the treatment of AIDS and HIV infection for the preparation of HIV infection and for inhibition of HIV protease and combination of compounds | |
ES2072092T3 (en) | STABILIZATION OF THYLENE COMPOSITIONS. | |
DE69902526D1 (en) | IMPROVING THE ANTIBACTERIAL EFFECT OF OXAZOLIDINONE BY ARGININE DERIVATIVES | |
AR247984A1 (en) | Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent | |
BR9804395A (en) | Long-acting, injectable pharmaceutical composition based on a tetracycline. | |
GT200100063A (en) | THE USE OF COMPOSITIONS BASED ON ANTIBIOTICS OF AZALIDES TO TREAT OR PREVENT A BACTERIAL INFECTION OR PROTOZOARY IN MAMMALS | |
CO4810296A1 (en) | DOUBLE COMPONENT ANTI-PLATE DENTRIFY COMPOSITION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09B | Decision: refusal |
Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM O ARTIGO 37 COM BASE NOS ARTIGOS 8O E 13 DA LPI |
|
B12B | Appeal: appeal against refusal |